Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
Journal: NEJM evidence
Published: February 06, 2024
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.
Journal: Cancer discovery
Published: August 16, 2023
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2022
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF©) and determination of a threshold score for moderate symptoms.
Journal: Orphanet journal of rare diseases
Published: October 06, 2021
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.
Journal: Nature medicine
Published: June 02, 2021
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF©.
Journal: Orphanet journal of rare diseases
Published: May 26, 2021
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study.
Journal: Orphanet journal of rare diseases
Published: May 21, 2021
Whole exome sequencing of a breast tumor in a patient with Diamond Blackfan anemia.
Journal: Blood cells, molecules & diseases
Published: March 28, 2021
Psychometric evaluation of the Advanced Systemic Mastocytosis Symptom Assessment Form (AdvSM-SAF).
Journal: Leukemia research
Published: December 14, 2020
Last Updated: 09/26/2026